(Q40588083)

21 September 2017

1 reference

title

Management of seizure disorders: selected aspects. Part I (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A784928

28 July 2022

1 reference

DeVivo DC

3

1 reference

21 September 2017

W. E. Dodson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A784928

28 July 2022

A. L. Prensky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A784928

28 July 2022

D. C. DeVivo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A784928

28 July 2022

S. Goldring

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A784928

28 July 2022

P. R. Dodge

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A784928

28 July 2022

language of work or name

English

0 references

publication date

1 October 1976

1 reference

The Journal of Pediatrics

21 September 2017

published in

1 reference

21 September 2017

volume

89

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

527-540

1 reference

Some Causes of Ineffectiveness of Diphenylhydantoin

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Intramuscular administration of phenytoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Plasma Levels of Diazepam After Parenteral and Rectal Administration in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Inadequate serum levels after intramuscular administration of diphenylhydantoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Intramuscular administration of diphenylhydantoin. Histologic follow-up studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Serum Concentrations of Diazepam in Subjects With Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Diphenylhydantoin (dilantin) sodium used parenterally in control of convulsions; a five-year report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Relationships between serum and cerebrospinal fluid anticonvulsant drug and folic acid concentrations in epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Diphenylhydantoin concentrations in saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Anticonvulsant drugs in human epileptogenic brain. Correlation of phenobarbital and diphenylhydantoin levels with plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Plasma Albumin Concentration and Diphenylhydantoin Binding in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Abnormal pharmacokinetics of phenytoin in a patient with uraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

7 January 2021

Drug-Protein Interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Passage of drugs across the placenta.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Diphenylhydantoin: Placental transport, fetallocalization, neonatal metabolism, and possible teratogenic effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Transplacental passage of primidone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

The Teratogenic Risk of Antiepileptic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Maternal barbiturate utilization and neonatal withdrawal symptomatology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Placental transfer of phenobarbitone in epileptic women, and elimination in newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Diazepam and breast-feeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Diazepam and breast-feeding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Antiepileptic Drugs: Biotransformation, Metabolism, and Serum Half-Life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Diphenylhydantoin Metabolism in Uremia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Metabolic disposition of primidone and its metabolites in epileptic subjects after single and repeated administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

The influence of diphenylhydantoin on primidone metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Urinary excretion of diphenylhydantoin metabolites in newborn infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Single daily dose of diphenylhydantoin in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Effect of dosage increments on blood phenytoin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Chronic and severe phenobarbital intoxication in a child treated with primidone and diphenylhydantoin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Interactions of Antiepileptic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Acute diphenylhydantoin intoxication following halothane anesthesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Intravenous diphenylhydantoin in experimental seizures. II. Effect on penicillin-induced seizures in the cat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Diphenylhydantoin: Efficacy, toxicity, and dose-serum level relationships in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Management of epilepsy with diphenylhydantoin sodium. Dosage regulation for problem patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Pharmacokinetics and side-effects of clonazepam and its 7- amino-metabolite in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Acute Toxicity of Antiepileptic Drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Primidone, diphenylhydantoin and phenobarbital: Aspects of acute and chronic toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

The distribution of plasma phenytoin levels in epileptic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

DIPHENYLHYDANTOIN ACTIVATED SEIZURES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

The neurologic hazards ofdiphenylhydantoin in childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Pseudodegenerative Disease Due to Diphenylhydantoin Intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Severe bradykinesia as a manifestation of toxicity to antiepileptic medications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Status Epilepticus History, Incidence and Problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Convulsive status epilepticus in infants and children. A study of 239 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Unusually severe lesions in the brain following status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

THE NEUROPATHOLOGY OF STATUS EPILEPTICUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Changes in Brain Lactate During Induced Cerebral Seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Cerebral Metabolism During Electrically Induced Seizures in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Physiology of Status Epilepticus in Primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Prolonged epileptic seizures in primates. Ischemic cell change and its relation to ictal physiological events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Systemic factors and epileptic brain damage. Prolonged seizures in paralyzed, artificially ventilated baboons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Destructive effects of prolonged status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Anoxia in mice: reduced glucose in brain with normal or elevated glucose in plasma and increased survival after glucose treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Cerebral energy metabolism during experimental status epilepticus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Temporary alteration of cerebrovascular permeability to plasma protein during drug-induced seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Astroglial swelling and phosphohydrolases in cerebral cortex of metrazol convulsant rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Intravenous diphenylhydantoin in experimental seizures. I. Correlation of dose, blood, and tissue level in cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Intravenous diphenylhydantoin in treatment of acute repetitive seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Intravenous Diazepam in the Treatment of Prolonged Seizure Activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Effect of chronic phenobarbital administration upon brain growth of the infant rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

TREATMENT OF STATUS EPILEPTICUS WITH DIAZEPAM (VALIUM).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Treatment of status epilepticus with diazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Benzodiazepines in the treatment of epilepsy. A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Diazepam treatment for acute convulsions in children. A report of 41 patients, three with plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

The estimation and significance of paraldehyde levels in blood and brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Metabolic acidosis occurring during paraldehyde intoxication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Epilepsia partialis continua.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

Absence Status A Reappraisal following Review of Thirty-eight Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

The Hemodynamic and Respiratory Effects of Diazepam (Valium®)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2876%2980381-2

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(76)80381-2

1 reference

21 September 2017

1 reference